EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papilloma

Christian Fiedler, Uwe R Kordes, Christian Thomas, Martin Hasselblatt, Brigitte Bison, Lars Behrens, Martin Mynarek, Rolf-Dieter Kortmann, Beate Timmermann, Torsten Pietsch, Jenny Adamski, Johannes E A Wolff und 2 weitere

Journal of Neuro-Oncology · 2025-10 · 175 (1) · 333-343

DOI: 10.1007/s11060-025-05136-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 26.06.2025. Verfasst von Christian Fiedler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Registries, Papilloma, Choroid Plexus, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Choroid plexus papilloma (CPP) and atypical choroid plexus papilloma (aCPP) have excellent outcomes. However, some CPP/aCPP relapse and may qualify for postoperative adjuvant treatment.

Methods

German patients from the International CPT-SIOP Registry diagnosed with CPP/aCPP between 2011 and 2023 were included and analysed according to initial staging (postoperative residual tumor [R+], metastases [M+]), biology, postoperative treatment strategy and outcome. Additionally, patients from the published CPT-SIOP-2000 trial (PMID34997889) were combined with the registry cohort for validation purpose.

Results

Ninety-three patients were identified (male: n = 53, female: n = 40). Median age at diagnosis was 1.9 (0.1–17.6) years. Initial staging was R0/M0 in n = 61, R+/M0 in n = 24, R0/M + in n = 5 and R+/M + in n = 3. aCPP was diagnosed in n = 38 patients. Molecular subgroup was available for n = 36: ”adult” n = 3, “pediatric A” n = 21 and “pediatric B” n = 12 (6/12 aCPP). Median follow-up was 5.5 (± 0.99) years. Twelve tumors relapsed: R0/M0 n = 4, R+/M0 n = 7, R+/M + n = 1. One patient with relapse died. Most patients did not receive postoperative treatment ( n = 88). Five patients (R0/M + n = 2; R+/M + n = 1; R0/M0 n = 2) received postoperative chemotherapy. None was irradiated during first-line treatment. In the enlarged cohort ( n = 197), histological diagnosis had a significant impact on PFS (5y-PFS: CPP 90 ± 3.1, aCPP 78.6 ± 4.6, PFS = 0.01). Both, R+ (5y-PFS: R0 90.6 ± 2.6, R + 69.1 ± 7.0, PFS = 0.01) as well as molecular subgroup “pediatric B” (5y-PFS: pediatric A 95.2%±3.3%, pediatric B: 69.5 ± 8.6%, PFS = 0.02), were associated with inferior PFS, especially in aCPP.

Conclusion

Incomplete resection and biology impact on PFS especially in aCPP. These results extend the evidence for current stratification and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesPapilloma, Choroid PlexusNeoplasm Recurrence, LocalHumansFemaleMaleChildChild, PreschoolAdolescentInfantDisease ProgressionRisk FactorsFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

Atypical choroid plexus papillomaChoroid plexus papillomaChoroid plexus tumor

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Neuropathology, University Hospital Münster, Münster, Germany.
  • Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Augsburg, Germany.
  • Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Radiation Oncology, University of Leipzig, Leipzig, Germany.
  • Department of Particle Therapy, West German Proton Therapy Centre Essen (WPE), University Hospital Essen, West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany.

Förderung

  • Universitätsklinikum Hamburg-Eppendorf (UKE)

Zitieren

APA

Fiedler, C., Kordes, U. R., Thomas, C., Hasselblatt, M., Bison, B., Behrens, L., Mynarek, M., Kortmann, R. D., Timmermann, B., Pietsch, T., Adamski, J., Wolff, J. E. A., Rutkowski, S., & Obrecht-Sturm, D. (2025). CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papilloma. Journal of Neuro-Oncology, 175(1), 333-343. https://doi.org/10.1007/s11060-025-05136-4

Vancouver

Fiedler C, Kordes UR, Thomas C, Hasselblatt M, Bison B, Behrens L, et al. CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papilloma. Journal of Neuro-Oncology. 2025;175(1):333-343. doi:10.1007/s11060-025-05136-4

BibTeX
@article{Fiedler2025,
  author = {Fiedler, Christian and Kordes, Uwe R and Thomas, Christian and Hasselblatt, Martin and Bison, Brigitte and Behrens, Lars and Mynarek, Martin and Kortmann, Rolf-Dieter and Timmermann, Beate and Pietsch, Torsten and Adamski, Jenny and Wolff, Johannes E A and Rutkowski, Stefan and Obrecht-Sturm, Denise},
  title = {CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papilloma},
  journal = {Journal of Neuro-Oncology},
  year = {2025},
  volume = {175},
  number = {1},
  pages = {333--343},
  doi = {10.1007/s11060-025-05136-4}
}
Kostenlos starten →